Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants

Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants

NCT01107587 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants

NCT00969228 ·Status: COMPLETED ·Phase: PHASE4

Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States

NCT00875641 ·Status: COMPLETED

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

NCT00140686 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

NCT00353366 ·Status: COMPLETED

Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants

NCT00480324 ·Status: COMPLETED ·Phase: PHASE3

To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants

NCT00420745 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.

NCT00432380 ·Status: COMPLETED ·Phase: PHASE2

Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.

NCT00420316 ·Status: COMPLETED ·Phase: PHASE3

Intussusception Surveillance After Rotarix Introduction in Mexico

NCT00595205 ·Status: COMPLETED

Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

NCT02914184 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine

NCT00757770 ·Status: COMPLETED ·Phase: PHASE3

Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

NCT00134732 ·Status: COMPLETED ·Phase: PHASE3

Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

NCT00137930 ·Status: COMPLETED ·Phase: PHASE2

Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

NCT00385320 ·Status: COMPLETED ·Phase: PHASE2

Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants

NCT00429481 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.

NCT01198769 ·Status: COMPLETED ·Phase: PHASE4

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).

NCT00382772 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults

NCT01162590 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks

NCT06025695 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.

NCT00140673 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children

NCT01177826 ·Status: COMPLETED

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

NCT00139347 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

NCT00197210 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Universal Rotavirus Vaccination Program

NCT01273077 ·Status: COMPLETED